Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0139 | 0.7813 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Brugia malayi | Proteasome A-type and B-type family protein | 0.0139 | 0.7813 | 1 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0884 | 0.113 |
Trichomonas vaginalis | abcb9, putative | 0.0032 | 0.0981 | 0.0815 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0139 | 0.7813 | 1 |
Brugia malayi | isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Mycobacterium leprae | proteasome (beta subunit) PrcB | 0.0139 | 0.7813 | 0.5 |
Toxoplasma gondii | kringle domain-containing protein | 0.003 | 0.0884 | 0.113 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.0032 | 0.0981 | 0.1254 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0032 | 0.0981 | 0.0815 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.003 | 0.0884 | 0.113 |
Brugia malayi | Kringle domain containing protein | 0.003 | 0.0884 | 0.1132 |
Schistosoma mansoni | hypothetical protein | 0.003 | 0.0884 | 0.0884 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0032 | 0.0981 | 0.0981 |
Plasmodium falciparum | multidrug resistance protein 1 | 0.0032 | 0.0981 | 0.1254 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0032 | 0.0981 | 0.0981 |
Echinococcus granulosus | proteasome prosome macropain | 0.0139 | 0.7813 | 0.7813 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0032 | 0.0981 | 0.0981 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.2218 | 0.2838 |
Trypanosoma brucei | proteasome subunit beta type-5, putative | 0.0139 | 0.7813 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0032 | 0.0981 | 0.0815 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.1315 | 0.1315 |
Leishmania major | ATP-binding cassette protein subfamily B, member 2, putative | 0.0032 | 0.0981 | 0.1254 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0035 | 0.1191 | 0.1525 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0139 | 0.7813 | 1 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.003 | 0.0884 | 0.1132 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | ABC transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0051 | 0.2218 | 0.2838 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.003 | 0.0884 | 0.113 |
Schistosoma mansoni | proteasome catalytic subunit 3 (T01 family) | 0.0139 | 0.7813 | 0.7813 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1315 | 0.0488 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0614 | 0.0786 |
Schistosoma mansoni | smdr2 | 0.0032 | 0.0981 | 0.0981 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0022 | 0.0375 | 0.0375 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.1315 | 0.1315 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0032 | 0.0981 | 0.0981 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0032 | 0.0981 | 0.0981 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.0032 | 0.0981 | 0.1256 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0.0614 | 0.0784 |
Entamoeba histolytica | proteasome subunit beta type 5 precursor, putative | 0.0139 | 0.7813 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1315 | 0.0488 |
Leishmania major | hypothetical protein, conserved | 0.0026 | 0.0614 | 0.0784 |
Schistosoma mansoni | multidrug resistance protein | 0.0032 | 0.0981 | 0.0981 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Brugia malayi | hypothetical protein | 0.0037 | 0.1315 | 0.1683 |
Brugia malayi | multidrug resistance protein 3 | 0.0032 | 0.0981 | 0.1256 |
Plasmodium vivax | proteasome subunit beta type-5, putative | 0.0139 | 0.7813 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0032 | 0.0981 | 0.0981 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.0031 | 0.0959 | 0.0959 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0981 | 0.1256 |
Plasmodium falciparum | proteasome subunit beta type-5 | 0.0139 | 0.7813 | 1 |
Brugia malayi | ABC transporter family protein | 0.0032 | 0.0981 | 0.1256 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0026 | 0.0614 | 0.0784 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0032 | 0.0981 | 0.0981 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Plasmodium vivax | multidrug resistance protein 1, putative | 0.0032 | 0.0981 | 0.1254 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1315 | 0.0488 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0032 | 0.0981 | 0.0815 |
Brugia malayi | Isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.1315 | 0.1315 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0981 | 0.1256 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0139 | 0.7813 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0026 | 0.0614 | 0.0784 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0016 | 0.0002 | 0.0002 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0.0614 | 0.0784 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Onchocerca volvulus | 0.0032 | 0.0981 | 1 | |
Trichomonas vaginalis | abcb9, putative | 0.0032 | 0.0981 | 0.0815 |
Toxoplasma gondii | proteasome subunit beta type, putative | 0.0139 | 0.7813 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.003 | 0.0884 | 0.1132 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Mycobacterium ulcerans | proteasome PrcB | 0.0139 | 0.7813 | 0.5 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.0032 | 0.0981 | 0.5 |
Echinococcus multilocularis | proteasome (prosome, macropain) | 0.0139 | 0.7813 | 0.7813 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0026 | 0.0614 | 0.0784 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0022 | 0.0375 | 0.0375 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0051 | 0.2218 | 0.2838 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0032 | 0.0981 | 0.0815 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0022 | 0.0375 | 0.0375 |
Schistosoma mansoni | multidrug resistance protein | 0.0032 | 0.0981 | 0.0981 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0032 | 0.0981 | 0.0981 |
Trichomonas vaginalis | ABC transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Toxoplasma gondii | ATP-binding cassette transporter ABC.B1 | 0.0032 | 0.0981 | 0.1254 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.1191 | 0.1191 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0032 | 0.0981 | 0.0981 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.0032 | 0.0981 | 0.1256 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0032 | 0.0981 | 0.0981 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0959 | 0.1228 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.003 | 0.0884 | 0.113 |
Brugia malayi | hypothetical protein | 0.0026 | 0.0614 | 0.0786 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.003 | 0.0884 | 0.0884 |
Echinococcus granulosus | tissue type plasminogen activator | 0.003 | 0.0884 | 0.0884 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0026 | 0.0614 | 0.0784 |
Trichomonas vaginalis | taga, putative | 0.0032 | 0.0981 | 0.0815 |
Giardia lamblia | Proteasome subunit beta type 5 precursor | 0.0139 | 0.7813 | 0.5 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0032 | 0.0981 | 0.0981 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0026 | 0.0614 | 0.0784 |
Brugia malayi | hypothetical protein | 0.0017 | 0.0032 | 0.0042 |
Leishmania major | p-glycoprotein | 0.0032 | 0.0981 | 0.1254 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.1315 | 0.0488 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.0031 | 0.0959 | 0.0959 |
Trichomonas vaginalis | ABC transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0032 | 0.0981 | 0.0981 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0032 | 0.0981 | 0.0981 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.1315 | 0.1315 |
Toxoplasma gondii | ABC transporter transmembrane region domain-containing protein | 0.0032 | 0.0981 | 0.1254 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0884 | 0.1132 |
Mycobacterium tuberculosis | Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. | 0.0139 | 0.7813 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0032 | 0.0981 | 0.0815 |
Schistosoma mansoni | multidrug resistance protein | 0.0032 | 0.0981 | 0.0981 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0032 | 0.0981 | 0.0815 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.1191 | 0.1525 |
Leishmania major | proteasome beta 5 subunit, putative | 0.0139 | 0.7813 | 1 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0032 | 0.0981 | 0.0981 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0016 | 0.0002 | 0.0002 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0032 | 0.0981 | 0.0815 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0051 | 0.2218 | 0.2838 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.